Furthermore, we identified a novel BC-DM-associated oncogene FIBCD1, which enhanced the malignancy of BC cells in a glucose level-dependent manner by promoting MCM5 expression through regulating histone acetylation modification in the MCM5 promoter. The gene discussed is FIBCD1; the disease is breast cancer.